| Glutamic acid as anticancer agent: An overview S Dutta, S Ray, K Nagarajan Saudi Pharmaceutical Journal 21 (4), 337-343, 2013 | 144 | 2013 |
| In vitro evaluation of protective effects of ascorbic acid and water extract of Spirulina plantesis (blue green algae) on 5-fluorouracil-induced lipid peroxidation S Ray, K Roy, C Sengupta Acta Pol Pharm 64 (4), 335-344, 2007 | 57 | 2007 |
| Evaluation of Protective Effects of Water Extract of Spirulina platensis (blue green algae) on Cisplatin-Induced Lipid Peroxidation. S Ray, K Roy, C Sengupta Indian Journal of Pharmaceutical Sciences 69 (3), 2007 | 43 | 2007 |
| Carnosic Acid, a Natural Diterpene, Attenuates Arsenic‐Induced Hepatotoxicity via Reducing Oxidative Stress, MAPK Activation, and Apoptotic Cell Death Pathway S Das, S Joardar, P Manna, TK Dua, N Bhattacharjee, R Khanra, ... Oxidative Medicine and Cellular Longevity 2018 (1), 1421438, 2018 | 38 | 2018 |
| Cyclophosphamide-Induced Lipid Peroxidation and Changes in Cholesterol Content: Protective Role of Reduced Glutathione: Cyclophosphamide induced lipid peroxidation S Ray, S Chakraborty, B Pandit, S Das Iranian Journal of Pharmaceutical Sciences 7 (4), 255-267, 2011 | 31 | 2011 |
| QSAR modeling of antiradical and antioxidant activities of flavonoids using electrotopological state (E-State) atom parameters S Ray, C Sengupta, K Roy Open Chemistry 5 (4), 1094-1113, 2007 | 30 | 2007 |
| Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent SD Ray, S Ray, M Zia-Ul-Haq, V De Feo, S Dewanjee BMC Complementary and Alternative Medicine 15, 1-11, 2015 | 26 | 2015 |
| Cisplatin-induced lipid peroxidation and its inhibition with ascorbic acid S Ray, K Roy, C Sengupta Indian journal of pharmaceutical sciences 68 (2), 199, 2006 | 26 | 2006 |
| QSAR modeling for lipid peroxidation inhibition potential of flavonoids using topological and structural parameters S Ray, C Sengupta, K Roy Open Chemistry 6 (2), 267-276, 2008 | 24 | 2008 |
| Evaluation of ascorbic acid as suppressor of cyclophosphamide induced lipid peroxidation using common laboratory markers S Ray, C Sengupta, K Roy Acta Pol Pharm-Drug Research 62, 145-51, 2005 | 20 | 2005 |
| Encapsulation of bioactive compound and its therapeutic potential L Pachuau, Laldinchhana, PK Roy, JH Zothantluanga, S Ray, S Das Bioactive Natural Products for Pharmaceutical Applications, 687-714, 2021 | 17 | 2021 |
| Exploring the antiperoxidative potential of morin on cyclophosphamide and flutamide-induced lipid peroxidation and changes in cholesterol profile in rabbit model S Ray, P Chowdhury, B Pandit, SD Ray, S Das Acta Pol Pharm 67 (1), 35-44, 2010 | 17 | 2010 |
| In Vitro Evaluation of Antiperoxidative Potential of Water Extract of Spirulina platensis (blue green algae) on Cyclophosphamide--Induced Lipid Peroxidation. S Ray, K Roy, C Sengupta Indian Journal of Pharmaceutical Sciences 69 (2), 2007 | 16 | 2007 |
| A study on ceftriaxone-induced lipid peroxidation using 4-hydroxy-2-nonenal as model marker S Chakraborty, PD Bhuti, S Ray, C Sengupta, K Roy neurodegenerative diseases 5, 6, 2005 | 15 | 2005 |
| Exploring the protective effect of ascorbic acid and water extract of Spirulina platensis (blue green algae) on methotrexate-induced lipid peroxidation S Ray, K Roy, C Sengupta Iranian J Pharm Sci 3, 217-28, 2007 | 13 | 2007 |
| Glutamic acid analogues used as potent anticancer: a review S Dutta, S Ray, K Nagarajan Der Pharma Chemica 3 (2), 263-272, 2011 | 12 | 2011 |
| QSAR study of lipid peroxidation-inhibition potential of some phenolic antioxidants S Ray, K De, C Sengupta, K Roy CSIR, 2008 | 12 | 2008 |
| A QSAR study of biphenyl analogues of 2-nitroimidazo-[2, 1-b][1, 3]-oxazines as antitubercular agents using genetic function approximation S Ray, P Pratim Roy Medicinal Chemistry 8 (4), 717-726, 2012 | 11 | 2012 |
| Exploring the Protective Effect of Ascorbic Acid and AqueousExtract of Spirulina platensison Methotrexate-Induced Lipid Peroxidation: Antioxidant effect of Spirulina platensis S Ray, K Roy, C Sengupta Iranian Journal of Pharmaceutical Sciences 3 (4), 217-228, 2007 | 11 | 2007 |
| Advances in hybrid vesicular-based drug delivery systems: improved biocompatibility, targeting, therapeutic efficacy and pharmacokinetics of anticancer drugs A Setia, RK Sahu, S Ray, R Widyowati, W Ekasari, S Saraf Current drug metabolism 23 (9), 757-780, 2022 | 8 | 2022 |
